Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'
Tweet Send to a Friend
Leerink Partners analyst David Risinger reiterated a Market Perform rating and $26.00 price target on Pfizer (NYSE: PFE)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
